ATAI Life Sciences NV (ATAI)
1.52
-0.07
(-4.40%)
USD |
NASDAQ |
Nov 21, 16:00
1.52
0.00 (0.00%)
After-Hours: 07:05
ATAI Life Sciences Profit Margin (Quarterly): -65.72K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -65.72K% |
| June 30, 2024 | -20.99K% |
| March 31, 2024 | |
| December 31, 2023 | -101.6K% |
| September 30, 2023 | |
| June 30, 2023 | -19.21K% |
| March 31, 2023 | -89.55K% |
| December 31, 2022 | -118.4K% |
| Date | Value |
|---|---|
| September 30, 2022 | -141.2K% |
| June 30, 2022 | -21.54K% |
| March 31, 2022 | |
| December 31, 2021 | -38.64K% |
| September 30, 2021 | -11.71K% |
| June 30, 2021 | |
| March 31, 2021 | 3.46% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-141.2K%
Minimum
Sep 2022
3.46%
Maximum
Mar 2021
-57.15K%
Average
-38.64K%
Median
Dec 2021
Profit Margin (Quarterly) Benchmarks
| Affimed NV | -9.77K% |
| InflaRx NV | -14.09K% |
| BioNTech SE | 15.91% |
| Immatics NV | -16.95% |
| CureVac NV | 68.44% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -61.19% |
| Return on Assets | -50.07% |
| Return on Invested Capital | -56.15% |
| Operating Margin (Quarterly) | -56.43K% |
| Return on Net Operating Assets | -1.22K% |